Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of IDE polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Goat |
| Applications | ELISA,WB-Ce,WB-Tr |
More info about IDE polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB7317 |
| Product name: | IDE polyclonal antibody |
| Product description: | Goat polyclonal antibody raised against synthetic peptide of IDE. |
| Gene id: | 3416 |
| Gene name: | IDE |
| Gene alias: | FLJ35968|INSULYSIN |
| Gene description: | insulin-degrading enzyme |
| Immunogen: | A synthetic peptide corresponding to human IDE. |
| Immunogen sequence/protein sequence: | C-QQYNFDRDNTE |
| Protein accession: | NP_004960.1 |
| Form: | Liquid |
| Concentration: | 0.5 mg/mL |
| Recommend dilutions: | ELISA (1:32000) Western Blot (0.1-0.3 ug/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In Tris saline, pH 7.3 (0.5% BSA, 0.02% sodium azide) |
| Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Goat |
| Antigen species / target species: | Human |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | IDE polyclonal antibody (Cat # PAB7317) (0.1 ug/mL) staining of K-562 cell lysate (35 ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence. |
| Applications: | ELISA,WB-Ce,WB-Tr |
| Shipping condition: | Dry Ice |
| Publications: | Insulin degrading enzyme activity selectively decreases in the hippocampal formation of cases at high risk to develop Alzheimer's disease.Zhao Z, Xiang Z, Haroutunian V, Buxbaum JD, Stetka B, Pasinetti GM. Neurobiol Aging. 2007 Jun;28(6):824-30. Epub 2006 Jun 12. |